This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| G. T. van Belle | |
|---|---|
| Name | G. T. van Belle |
| Occupation | Biostatistician; Methodologist; Academic |
| Known for | Experimental design; Nonparametric statistics; Reproducible research |
G. T. van Belle. G. T. van Belle is a biostatistician and quantitative methodologist known for contributions to experimental design, sample size determination, and nonparametric techniques. Van Belle has held academic appointments and collaborated with clinical researchers, epidemiologists, and public health institutions, influencing practice in clinical trials, diagnostic testing, and comparative effectiveness research.
Van Belle completed advanced training in statistics and quantitative methods. His education included doctoral-level study and postdoctoral research in statistical methodology at institutions that emphasize applied medicine and public health, with intellectual ties to figures affiliated with Harvard T.H. Chan School of Public Health, Johns Hopkins Bloomberg School of Public Health, University of Washington School of Public Health, and University of California, Berkeley. Early mentors and collaborators have included scholars connected to the National Institutes of Health, the Centers for Disease Control and Prevention, and research groups with links to the World Health Organization and National Science Foundation.
Van Belle has held faculty positions and visiting appointments in departments bridging statistics, biostatistics, and clinical research. His roles have been associated with universities and medical centers that collaborate with entities such as Mayo Clinic, Massachusetts General Hospital, University of Michigan Health System, and Stanford University School of Medicine. Administrative and program leadership roles placed him in contact with professional societies including the American Statistical Association, the International Biometric Society, and the Royal Statistical Society. His career spans collaborations with research networks funded by agencies like the National Cancer Institute and the Agency for Healthcare Research and Quality.
Van Belle’s research emphasizes design and analysis techniques applicable to clinical trials, diagnostic accuracy studies, and longitudinal analyses. He has published methodological work addressing power analysis, confidence intervals, and the use of nonparametric procedures in small-sample settings, with bibliographic presence alongside texts associated with Wiley, Springer, and university presses. His publications have been cited in contexts related to New England Journal of Medicine, The Lancet, Journal of the American Medical Association, Biometrika, and Statistics in Medicine. Topics intersect with analytic frameworks used by investigators at Dana-Farber Cancer Institute, National Heart, Lung, and Blood Institute, and Fred Hutchinson Cancer Research Center. His methodological contributions inform diagnostic accuracy studies referencing STARD (statement), randomized controlled trials referencing CONSORT, and comparative studies used in guidelines by Food and Drug Administration panels. Van Belle’s work also interacts with algorithms and software maintained by projects associated with R Project for Statistical Computing, SAS Institute, and packages cited in publications by researchers from Imperial College London and University College London.
As an educator, Van Belle has taught courses and workshops on statistical inference, experimental design, and clinical trial methodology to audiences drawn from medical schools, research institutes, and government agencies. His instructional reach has connected trainees who later held positions at institutions such as Columbia University Vagelos College of Physicians and Surgeons, Yale School of Medicine, University of California, San Francisco School of Medicine, and Kaiser Permanente. He has supervised graduate students and postdoctoral fellows who pursued careers in academic departments, regulatory agencies, and industry research at organizations including Pfizer, Johnson & Johnson, and GlaxoSmithKline. Van Belle’s pedagogical materials have been incorporated into curricula alongside texts used at Cornell University, Carnegie Mellon University, and Duke University School of Medicine.
Van Belle’s professional recognition includes peer-awarded honors and invited lectureships from statistical and medical organizations. He has been invited to speak at meetings organized by the Society for Clinical Trials, the Eastern North American Region (ENAR) of the International Biometric Society, and the Royal Statistical Society. His work has received citations and acknowledgments in policy documents produced by the Institute of Medicine (now the National Academy of Medicine), and he has been associated with panels sponsored by the National Institutes of Health and the European Medicines Agency.
Van Belle has served on scientific program committees and editorial boards for journals and conferences in biostatistics and clinical research. Editorial engagements have included service for journals aligned with publishers such as Elsevier, Oxford University Press, and Taylor & Francis Group, and participation on panels convened by American Association for the Advancement of Science conferences and meetings of the American Statistical Association. Conference presentations and symposia appearances have linked him with research forums at International Conference on Machine Learning, Joint Statistical Meetings, and thematic workshops organized by Cold Spring Harbor Laboratory and Gordon Research Conferences.
Category:Biostatisticians Category:Methodologists